<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635881"><TermName>ICE</TermName><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin and Hodgkin lymphomas that have come back and do not respond to other treatments. It includes the drugs ifosfamide, carboplatin, and etoposide phosphate. Also called ICE regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000734725" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ICE&quot;" language="en" id="_3"/><SpanishTermName>ICE</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa para tratar el linfoma de Hodgkin y el linfoma no Hodgkin que reaparecieron y no respondieron a otros tratamientos. Contiene los medicamentos ifosfamida, carboplatino y fosfato de etopósido. También se llama régimen ICE.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-23</DateFirstPublished><DateLastModified>2010-05-05</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000635672">ICE</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
